Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung
- 31 October 2005
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 50 (1) , 1-8
- https://doi.org/10.1016/j.lungcan.2005.04.012
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJNCI Journal of the National Cancer Institute, 2005
- Bronchioloalveolar Carcinoma of the Lung 3 Centimeters or Less in Diameter: A Prognostic AssessmentThe Annals of Thoracic Surgery, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- K-ras Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt ActivationThe American Journal of Pathology, 2004
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Monoclonality of Atypical Adenomatous Hyperplasia of the LungThe American Journal of Pathology, 1999
- High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungsZeitschrift für Krebsforschung und Klinische Onkologie, 1995